The present invention relates to quinazolinones of formula (I) wherein R.sup.1 is hal; a); b); or c); X is N or CR.sup.8; R.sup.2 is hal; nitro; C.sub.1-C.sub.6alkylcarbonyl; C.sub.1-C.sub.6alkyl or C.sub.3-C.sub.6cycloalkyl; R.sup.3 is C.sub.1-C.sub.6alkyl; C.sub.1-C.sub.6alkoxy or amino; and wherein the further radicals have the meanings as defined in the specification, which compounds exhibit human vanilloid antagonistic activity; to processes for their production, their use as pharmaceuticals and to pharmaceutical compositions comprising them.

 
Web www.patentalert.com

< Novel inhibitors of lysyl oxidase

> METHOD AND DEVICE FOR QUICK PRESS ON EEG ELECTRODE

~ 00480